-
ISEH 2025 China–Japan Dialogue | Prof. Jianxiang Wang and Prof. Naoki Hosen: Direct Insights into CAR-T Therapy for Leukemia and a New Blueprint for International Collaboration
The 54th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH 2025) was held in Kumamoto, Japan, from September 24–27. The conference brought together leading experts in hematology from around the world to discuss cutting-edge progress in basic hematology, immunology, stem cell research, and cell and gene therapies. During the meeting, Oncology Frontier…
-
CSCO 2025 | Professor Ma Jun: 120 Years of Chinese Hematology Establishing a Global Benchmark – CSCO Annual Meeting to Decode Innovative Therapies and Cutting-Edge Breakthroughs
In the field of hematologic malignancies, top experts from China and abroad will present a rich scientific program covering lymphoma, myeloma, leukemia, and other core diseases. The agenda will feature…
-
TCT Literature Express | Professors Ke Xiaoyan and Hu Kai: Preemptive CD20 CAR-T Therapy Prolongs Survival in Partial Responders after CD19 CAR-T
CD20 is widely expressed on the surface of B cells and represents an attractive therapeutic target for CAR-T therapy. CD20 CAR-T therapy has already demonstrated encouraging efficacy in patients with…
Connecting Medical Expertise through Media